Soleno Therapeutics
SLNO
#4290
Rank
NZ$4.94 B
Marketcap
NZ$94.89
Share price
0.00%
Change (1 day)
-15.45%
Change (1 year)

Earnings for Soleno Therapeutics (SLNO)

Earnings in 2026 (TTM): NZ$0.18 Billion

According to Soleno Therapeutics's latest financial reports the company's current earnings are NZ$0.28 Billion. In 2025 the company made an earning of NZ$47.19 Million, an increase over its 2024 earnings that were of -NZ$0.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soleno Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.18 B285.43%
2025 NZ$47.19 M-115.52%
2024 -NZ$0.31 Billion339.22%
2023 -NZ$69.22 Million54.01%
2022 -NZ$44.95 Million-22.16%
2021 -NZ$57.75 Million0.97%
2020 -NZ$57.19 Million37.73%
2019 -NZ$41.53 Million96.94%
2018 -NZ$21.09 Million21.69%
2017 -NZ$17.33 Million-23.69%
2016 -NZ$22.71 Million-20.82%
2015 -NZ$28.68 Million86%
2014 -NZ$15.42 Million829.91%
2013 -NZ$1.66 Million